Chronic Diseases and Translational Medicine : Impact Factor & More
eISSN: 2589-0514pISSN: 2095-882X
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chronic Diseases and Translational Medicine
Chronic Diseases and Translational Medicine Journal Specifications
| Overview | |
| Publisher | Wiley |
| Language | English |
| Article Processing Charges | USD 2650 |
| Publication Time | 14 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Chronic Diseases and Translational Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chronic Diseases and Translational Medicine
Cardiovascular Risk Assessment and Its Determinants Among Older Adults in India: Evidence From a Nationally Representative Survey
- 3 May 2026
- Chronic Diseases and Translational Medicine
GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes
- 24 Mar 2026
- Chronic Diseases and Translational Medicine
Synergistic Effects of Normal‐Range Serum Sodium and Potassium on Mortality: The Modifying Role of Inflammation From a NHANES Cohort Analysis
- 2 Mar 2026
- Chronic Diseases and Translational Medicine
The Promoting Angiogenesis and Its Clinical Significance of CD33+Myeloid Derived Suppressor Cells Derived From Small Cell Lung Cancer.
- 1 Mar 2026
- Chronic diseases and translational medicine
Rapid Recognition of Carfilzomib-Induced Thrombotic Microangiopathy and Early Application of Eculizumab Successfully Rescued Two Relapsed Myeloma Patients.
- 1 Mar 2026
- Chronic diseases and translational medicine
Guide for Authors.
- 1 Mar 2026
- Chronic diseases and translational medicine
Cardiovascular Risk Assessment and Its Determinants Among Older Adults in India: Evidence From a Nationally Representative Survey
- 3 May 2026
- Chronic Diseases and Translational Medicine
GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes
- 24 Mar 2026
- Chronic Diseases and Translational Medicine
Synergistic Effects of Normal‐Range Serum Sodium and Potassium on Mortality: The Modifying Role of Inflammation From a NHANES Cohort Analysis
- 2 Mar 2026
- Chronic Diseases and Translational Medicine
The Promoting Angiogenesis and Its Clinical Significance of CD33+Myeloid Derived Suppressor Cells Derived From Small Cell Lung Cancer.
- 1 Mar 2026
- Chronic diseases and translational medicine
Rapid Recognition of Carfilzomib-Induced Thrombotic Microangiopathy and Early Application of Eculizumab Successfully Rescued Two Relapsed Myeloma Patients.
- 1 Mar 2026
- Chronic diseases and translational medicine
Guide for Authors.
- 1 Mar 2026
- Chronic diseases and translational medicine
FAQs on Chronic Diseases and Translational Medicine
How many articles did Chronic Diseases and Translational Medicine publish last year? 
What is the eISSN & pISSN for Chronic Diseases and Translational Medicine?
Who is the publisher of Chronic Diseases and Translational Medicine?
